Drug intelligence / Profile preview

mucuna pruriens seed extract

Development stage
Preclinical
Lead developer
Himalaya Wellness Company
Modality
Small Molecules
Administration
Oral
01

Overview

Mucuna pruriens seed extract is a botanical derivative from the velvet bean plant, widely recognized for its high natural content of levodopa (L-DOPA), the metabolic precursor to dopamine. It is primarily used as a natural alternative or adjunct to synthetic L-DOPA for the management of Parkinson's disease, as it effectively crosses the blood-brain barrier to replenish striatal dopamine levels. Beyond its dopaminergic activity, the extract contains a variety of bioactive compounds including alkaloids, phenolics, and flavonoids that contribute to its antioxidant and anti-inflammatory properties. Research indicates it can reduce oxidative stress by scavenging free radicals and inhibiting lipid peroxidation, while also modulating neuroinflammatory signaling pathways such as NF-κB and iNOS. It is also utilized in traditional medicine for treating male infertility and is being explored for its potential anti-diabetic and antidepressant effects.

Brand names
ZandopaHP-200HP200HP 200
Other names
velvet bean extractcowitch extractKapikacchuMucuna pruriens
02

Targets

AcetylcholinesteraseDRD (Dopamine receptors)

Beyond the preview

Go deeper on mucuna pruriens seed extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mucuna pruriens seed extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call